Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: April 2010
-
Patent Resources Group (PRG) will be offering a one-day conference on "The Future of U.S. Patent Law: An In-Depth Discussion on the Congress, the Courts, and the USPTO" on June 11, 2010 from 9:00 AM to 4:30 PM at Buchanan Ingersoll and Rooney PC in Alexandria, VA. According to the PRG website, the in-depth panel…
-
The Intellectual Property Law Association of Chicago (IPLAC) will offer a panel discussion entitled: "The Role of Patent Agents in Intellectual Property in the Changing Economy" on May 18, 2010 from 1:00 to 4:00 PM (CDT) at the John Marshall Law School in Chicago, IL. The panel discussion, which is being sponsored by IPLAC's Patent…
-
C5 (UK) will be holding its 7th International Forum on Freedom to Operate on May 26-27, 2010 in Munich, Germany. The conference will provide practical advice on the biggest challenges facing freedom to operate (FTO) assessments, including: • How to effectively manage the FTO process to ensure the lowest cost, the highest value, and the…
-
By Donald Zuhn — On April 6, the Federal Circuit, in MedPointe Healthcare, Inc. v. Kozachuk, affirmed a decision of the District Court for the District of New Jersey enforcing a settlement agreement regarding the transfer of ownership of U.S. Patent Nos. 5,728,728, 5,942,540, and 6,515,019, which are directed to clinical uses of the…
-
By Sarah Fendrick — In a notice published in the Federal Register (75 Fed. Reg. 15417), the U.S. Patent and Trademark Office (USPTO) announced that it is seeking nominations for three members to both the Patent and Trademark Public Advisory Committees. The Public Advisory Committees serve to review the policies, goals, performance, budget, and…
-
By Donald Zuhn — Sherry Knowles, Senior Vice President, Global Patents for GlaxoSmithKline has announced that she will be leaving GSK in June to start a consulting firm that will focus on IP management, business development, and monetizing assets in the area of pharmaceuticals, biopharmaceuticals, and medical devices. Ms. Knowles (at right), who has…
-
By Kevin E. Noonan — It is a bedrock principle of patent practice that the U.S. Patent and Trademark Office gives the terms of claims under examination their broadest reasonable construction. The rationale is that, in this way, the applicant has the opportunity to argue or amend the claims to be as broad as…
-
By Sarah Fendrick — Last week, the U.S. Patent and Trademark Office announced the launch of a new ombudsman pilot program that will provide patent applicants with more assistance with application processing problems. The new pilot program allows applicants experiencing problems during processing to contact an ombudsman representative. The ombudsman representative will call the…
-
By Donald Zuhn — On March 26, the Federal Circuit reversed the judgment of the District Court for the District of Connecticut that U.S. Patent Nos. 5,328,824 and 5,449,767 are invalid, affirmed the judgment of the District Court that U.S. Patent No. 5,476,928 is anticipated, and affirmed the judgment of the District Court that…
-
By Kevin E. Noonan — The problem, according to the academics and the pundits, is that patent exclusivity in certain areas (such as gene patents) could result in a "tragedy of the anti-commons," inhibiting innovation. One of the many manifestations of this tragedy, according to such august bodies as the National Academy of Science…
Patent Docs 